Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Klotz, Laura Valentina [VerfasserIn]   i
 Casjens, Swaantje [VerfasserIn]   i
 Johnen, Georg [VerfasserIn]   i
 Taeger, Dirk [VerfasserIn]   i
 Brik, Alexander [VerfasserIn]   i
 Eichhorn, Florian [VerfasserIn]   i
 Förster, Laura [VerfasserIn]   i
 Kaiser, Nina [VerfasserIn]   i
 Muley, Thomas [VerfasserIn]   i
 Stolp, Christa [VerfasserIn]   i
 Schneider, Marc [VerfasserIn]   i
 Gleichenhagen, Jan [VerfasserIn]   i
 Brüning, Thomas [VerfasserIn]   i
 Winter, Hauke [VerfasserIn]   i
 Eichhorn, Martin E. [VerfasserIn]   i
 Weber, Daniel G. [VerfasserIn]   i
Titel:Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients
Verf.angabe:Laura V. Klotz, Swaantje Casjens, Georg Johnen, Dirk Taeger, Alexander Brik, Florian Eichhorn, Laura Förster, Nina Kaiser, Thomas Muley, Christa Stolp, Marc Schneider, Jan Gleichenhagen, Thomas Brüning, Hauke Winter, Martin Eichhorn, Daniel G. Weber
E-Jahr:2024
Jahr:June 2024
Umfang:8 S.
Illustrationen:Illustrationen
Fussnoten:Online verfügbar: 24. April 2024, Artikelversion: 1. Mai 2024 ; Gesehen am 11.10.2024
Titel Quelle:Enthalten in: Lung cancer
Ort Quelle:Amsterdam [u.a.] : Elsevier, 1985
Jahr Quelle:2024
Band/Heft Quelle:192(2024) vom: Juni, Artikel-ID 107802, Seite 1-8
ISSN Quelle:1872-8332
Abstract:Background - The role of cytoreductive surgery for epithelioid pleural mesothelioma within a multimodal treatment approach remains controversial. Carefully selected patients benefit from cytoreductive surgery and adjuvant chemotherapy, but there is no established biomarker to predict tumor recurrence or progression during the course of the disease. The aim of this study was to identify potential biomarkers to predict therapeutic response in terms of progression-free survival. - Methods - Between 03/2014 and 08/2022, preoperative blood samples were collected from 76 patients with epithelioid pleural mesothelioma who underwent cytoreductive surgery as part of a multimodal treatment approach. Identification of potential biomarkers was performed by determination of mesothelin and calretinin, as well as specific long non-coding RNAs and microRNAs. Receiver operating characteristic analysis, Kaplan-Meier survival analysis, and Cox regression were used to assess the association between biomarker concentrations and patient recurrence status and survival. - Results - MALAT1, GAS5, and calretinin showed statistically significant increased biomarker levels in patients with recurrence in contrast to recurrence-free patients after surgical treatment (p < 0.0001, p = 0.0190, and p = 0.0068, respectively). The combination of the three biomarkers resulted in a sensitivity of 68 % and a specificity of 89 %. - Conclusion - MALAT1, GAS5, and calretinin could be potential biomarkers for the prediction of tumor recurrence, improving the benefit from multimodal treatment including cytoreductive surgery.
DOI:doi:10.1016/j.lungcan.2024.107802
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1016/j.lungcan.2024.107802
 kostenfrei: Volltext: https://www.sciencedirect.com/science/article/pii/S0169500224003362
 DOI: https://doi.org/10.1016/j.lungcan.2024.107802
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Biomarker
 Calretinin
 Cytoreductive surgery
 Decortication
 GAS5
 MALAT1
 Mesothelioma
 Thoracic surgery
 Tumor recurrence
K10plus-PPN:1905486286
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69261610   QR-Code
zum Seitenanfang